Head to Head Contrast: DarioHealth (NASDAQ:DRIO) & Doximity (NYSE:DOCS)

Doximity (NYSE:DOCS) and DarioHealth (NASDAQ:DRIO) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations and dividends.

Profitability

This table compares Doximity and DarioHealth’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Doximity	25.48%	18.06%	15.40%
DarioHealth	-169.87%	-54.81%	-33.36%

Risk & Volatility

Doximity has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, DarioHealth has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500.

Earnings & Valuation

This table compares Doximity and DarioHealth”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Doximity	$644.86 million	6.97	$196.05 million	$0.85	29.68
DarioHealth	$22.36 million	3.28	-$41.71 million	($6.13)	-1.22

Doximity has higher revenue and earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

87.2% of Doximity shares are held by institutional investors. Comparatively, 33.4% of DarioHealth shares are held by institutional investors. 31.8% of Doximity shares are held by insiders. Comparatively, 3.5% of DarioHealth shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings for Doximity and DarioHealth, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Doximity	4	12	7	2	2.28
DarioHealth	1	1	2	0	2.25

Doximity currently has a consensus target price of $32.43, suggesting a potential upside of 28.53%. DarioHealth has a consensus target price of $10.00, suggesting a potential upside of 33.51%. Given DarioHealth’s higher possible upside, analysts plainly believe DarioHealth is more favorable than Doximity.

Summary

Doximity beats DarioHealth on 14 of the 15 factors compared between the two stocks.

About Doximity

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical companies and health systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.